![OPTKAS Logo](assets/optkas-logo.png)

---

# SIMULATED LENDER DILIGENCE CALL â€” TOP 25 QUESTIONS
## OPTKAS1 LLC â€” Institutional Diligence Pack

**Date:** February 9, 2026  
**Version:** v2.0 | **Owner:** OPTKAS1 PMO  
**Contact:** jimmy@optkas.com  
**Format:** 45-minute structured call  
**Lender Side:** Managing Director (Credit) Â· Outside Counsel Â· Ops (Custody/Settlement) Â· Compliance (AML/SoF)

---

## CALL STRUCTURE

| Block | Duration | Lender Lead | Focus | Questions |
|:------|:---------|:-----------|:------|:----------|
| **A** | 10 min | Credit MD | Deal structure, collateral, credit thesis | Q1â€“Q5 |
| **B** | 10 min | Ops | Custody, settlement, account control | Q6â€“Q10 |
| **C** | 10 min | Outside Counsel | Legal enforceability, security, perfection | Q11â€“Q15 |
| **D** | 10 min | Compliance | KYC, AML, source of funds, sanctions | Q16â€“Q20 |
| **E** | 5 min | All | Commercial terms, timeline, gaps | Q21â€“Q25 |

---

## BLOCK A: CREDIT MD â€” DEAL STRUCTURE & COLLATERAL

---

### Q-01: What exactly is the facility request and cap?

**Who asks:** Managing Director (Credit)

**Best answer:**  
Asset-backed secured credit facility. $75Mâ€“$300M per institution, $2B maximum aggregate capacity. 40% loan-to-value advance rate against $5B face value collateral ($3B cost basis). Overcollateralization ratio 250%+. First-priority perfected security interest via UCC-1 + Account Control Agreement at STC.

**Evidence:** `01_EXECUTIVE_OVERVIEW/01.01 Executive Summary.pdf`  
**CP:** CP-01, CP-03  
**Gap:** ðŸŸ¢ None â€” documents on file

---

### Q-02: Define the collateral â€” issuer, CUSIP, face vs basis, restrictions.

**Who asks:** Credit MD / Analyst

**Best answer:**  
500 units of TC Advantage 5% Secured Medium Term Notes. Issuer: TC Advantage Traders, Ltd. (Reg# 205197B, Freeport, Grand Bahama). CUSIP 144A: 87225HAB4, Reg S: P9000TAA8. Face value $5B ($10M Ã— 500 notes). Cost basis $3B ($6M per note). 5% annual coupon, maturity May 31, 2030. Book-entry only, held at STC. 144A/Reg S restricted securities. Issuance authorized January 22, 2026 by board resolution; fully paid and non-assessable.

**Evidence:** `03_COLLATERAL_DOCUMENTATION/03.01 Private Placement Memorandum (May 29, 2020).pdf` + `03_COLLATERAL_DOCUMENTATION/03.07 Issuance Resolution (Jan 22, 2026).pdf`  
**CP:** CP-06  
**Gap:** ðŸŸ¢ None â€” PPM (47 pages) + Issuance Resolution on file

---

### Q-03: Why is 40% advance appropriate, and how is 250%+ coverage computed?

**Who asks:** Credit Analyst

**Best answer:**  
40% LTV is conservative by design â€” most note-backed ABL facilities operate at 50â€“70% LTV. The advance rate is applied to face value ($5B Ã— 40% = $2B max). Coverage ratio = face value Ã· maximum advance = 250%. Even against cost basis ($3B), coverage at full $2B advance is 150%. The Borrowing Base Policy documents the haircut methodology. Monthly BBC updates are a post-closing covenant.

**Evidence:** `01_EXECUTIVE_OVERVIEW/01.04 Borrowing Base Policy.pdf` + `07_FINANCIAL/07.01 Borrowing Base Certificate (initial).pdf`  
**CP:** CP-11, CP-17  
**Gap:** ðŸŸ¡ CP-18 (Valuation memo / Broker Opinion of Value) â€” **PRIMARY GATING ITEM**. Cost basis is anchored by Issuance Resolution. Recommend producing BOV to close this.

---

### Q-04: What are the top 5 risks and mitigants?

**Who asks:** Credit MD

**Best answer:**  
(1) **Collateral liquidity** â€” Mitigant: DTC/DWAC eligible, book-entry at STC, 144A/Reg S transferable. (2) **Issuer credit** â€” Mitigant: 250%+ overcollateralization; $625M insurance; coupon provides 16.7x DSCR. (3) **SPV newness** â€” Mitigant: Single-purpose bankruptcy-remote by design; no operating risk. (4) **Bahamas-domiciled issuer** â€” Mitigant: K. Knowles opinion covers both Bahamas + US law; lender perfects under Wyoming/NY UCC. (5) **Concentration** â€” Mitigant: Single-issuer concentration is standard for note-backed facilities; insurance diversifies recovery.

**Evidence:** `08_LENDER_PACKAGE/08.02 Credit Committee Positioning Brief.pdf`  
**CP:** CP-12  
**Gap:** ðŸŸ¢ None

---

### Q-05: What is the default plan and enforcement path?

**Who asks:** Credit MD / Counsel

**Best answer:**  
Upon event of default: (1) Lender issues notice to STC under Control Agreement â€” no borrower cooperation needed. (2) STC transfers or holds notes per lender instruction (UCC 8-106 control). (3) Lender can direct sale via DTC/DWAC settlement. (4) Insurance claim filed with C.J. Coleman if applicable. (5) UCC foreclosure via Wyoming filing. Base case recovery: 90â€“100% (overcollateralized). Stress: 60â€“80%. Catastrophic: 30â€“45%.

**Evidence:** `05_LEGAL/05.03 Security Agreement.pdf` + `05_LEGAL/05.05 Account Control Agreement â€” STC.pdf`  
**CP:** CP-30, CP-31  
**Gap:** ðŸŸ¢ Templates ready â€” finalize during negotiation

---

## BLOCK B: OPS â€” CUSTODY, SETTLEMENT & ACCOUNT CONTROL

---

### Q-06: Who is custodian and what exactly is held there?

**Who asks:** Operations / Custody team

**Best answer:**  
Securities Transfer Corporation (STC), 2901 Dallas Parkway Suite 380, Plano, Texas 75093. STC acts as transfer agent and registrar. 500 units of TC Advantage 5% Notes held in book-entry form in OPTKAS1 LLC's account. STC was authorized by the issuer's board resolution to issue notes and maintain the official ledger.

**Evidence:** `03_COLLATERAL_DOCUMENTATION/03.03 STC Security List by Issuer (Jan 23, 2026).pdf`  
**CP:** CP-07  
**Gap:** ðŸŸ¡ CP-21 â€” Holder-specific STC position statement (3â€“5 BD upon request). Issuer-level list available immediately.

---

### Q-07: How does control work (control agreement / account control)?

**Who asks:** Operations / Counsel

**Best answer:**  
Tri-party Account Control Agreement between OPTKAS1 LLC (borrower), STC (securities intermediary), and lender. Gives lender "control" under UCC 8-106. Normal operations: borrower receives coupon payments. Default: lender issues instructions directly to STC without borrower consent â€” transfer, sell, or hold. EagleBank (7815 Woodmont Ave, Bethesda, MD 20814) serves as escrow agent for cash proceeds.

**Evidence:** `05_LEGAL/05.05 Account Control Agreement â€” STC.pdf`  
**CP:** CP-31  
**Gap:** ðŸŸ¢ Template ready â€” requires STC coordination to execute

---

### Q-08: What is the timeline to confirm holder-specific position?

**Who asks:** Operations

**Best answer:**  
3â€“5 business days from request. Borrower contacts STC, requests Position Statement specifically addressed to lender confirming: (1) notes held in OPTKAS1 LLC's account, (2) current position (500 notes, $5B face), (3) no liens or encumbrances. Lender can also contact STC directly using verification instructions in Folder 09.

**Evidence:** `09_VERIFICATION/09.02 STC Contact Information & Verification Process.pdf`  
**CP:** CP-19, CP-21  
**Gap:** ðŸŸ¢ Process documented; 3â€“5 BD turnaround

---

### Q-09: Can settlement occur without borrower cooperation after default?

**Who asks:** Operations / Counsel

**Best answer:**  
Yes. The Account Control Agreement gives the lender the right to issue instructions directly to STC without borrower consent after an event of default. STC is contractually obligated to follow lender's instructions. This is the entire purpose of "control" under UCC 8-106. No court order required for STC to comply.

**Evidence:** `05_LEGAL/05.05 Account Control Agreement â€” STC.pdf`  
**CP:** CP-31  
**Gap:** ðŸŸ¢ Standard ACA mechanics

---

### Q-10: Any operational dependencies (DTC, DWAC, etc.)?

**Who asks:** Operations

**Best answer:**  
Notes are DTC/DWAC eligible. STC participates in the DTC FAST system, which implies book-entry eligibility. Settlement can occur via Deposit/Withdrawal at Custodian. Formal DTC/DWAC eligibility letter available upon request (2â€“3 BD). CUSIPs registered: 87225HAB4 (144A), P9000TAA8 (Reg S).

**Evidence:** `03_COLLATERAL_DOCUMENTATION/DTC_DWAC_Eligibility.pdf` + `09_VERIFICATION/09.03 CUSIP / ISIN Cross-Reference.pdf`  
**CP:** CP-26  
**Gap:** ðŸŸ¢ Formal letter available 2â€“3 BD

---

## BLOCK C: COUNSEL â€” LEGAL ENFORCEABILITY & PERFECTION

---

### Q-11: What reliance can lender take on your legal opinion?

**Who asks:** Outside Counsel

**Best answer:**  
K. Knowles & Co. (Suite D, Bain Building, Freeport, Grand Bahama) issued an 8-page opinion January 13, 2026 containing 6 formal opinions: (1) valid issuance, (2) proper authorization, (3) binding obligation of issuer, (4) compliance with offering documents, (5) eligible collateral status, (6) enforceability of security interest. Opinion covers both Bahamas and US law. Reliance language should be confirmed with lender's counsel â€” borrower will request K. Knowles to extend reliance if needed.

**Evidence:** `05_LEGAL/05.01 Legal Opinion â€” K. Knowles & Co. (Jan 13, 2026).pdf`  
**CP:** CP-09  
**Gap:** ðŸŸ¡ CP-39 â€” Lender may request supplemental US-qualified opinion. Borrower cooperates fully.

---

### Q-12: What law governs the security agreement and where is collateral located legally?

**Who asks:** Counsel

**Best answer:**  
Facility Agreement, Security Agreement, and Pledge Agreement governed by New York law (standard for institutional credit facilities). UCC-1 filed in Wyoming (borrower's state of formation). Control Agreement governed by New York law. Notes held at STC in Texas. Collateral "located" for UCC purposes at debtor's jurisdiction (Wyoming). K. Knowles opinion covers Bahamas law aspects of underlying notes.

**Evidence:** `05_LEGAL/05.03 Security Agreement.pdf`  
**CP:** CP-30  
**Gap:** ðŸŸ¢ Templates ready

---

### Q-13: UCC â€” who is debtor, collateral description, filing jurisdiction?

**Who asks:** Counsel

**Best answer:**  
Debtor: OPTKAS1 LLC (Wyoming Series LLC, File# 2025-001184729). Collateral description: All right, title, and interest in 500 units of TC Advantage 5% Secured Medium Term Notes (CUSIP 87225HAB4 / P9000TAA8) held at STC, together with all proceeds, distributions, and coupon payments. Filing jurisdiction: Wyoming Secretary of State. UCC-1 form ready to file upon execution.

**Evidence:** `05_LEGAL/05.06 UCC-1 Financing Statement.pdf`  
**CP:** CP-33  
**Gap:** ðŸŸ¢ Ready to file

---

### Q-14: Any restrictions on pledge/transfer of the notes?

**Who asks:** Counsel

**Best answer:**  
Notes are 144A/Reg S restricted securities. Transfer restrictions apply per the PPM and customary 144A/Reg S legends. However, pledge to an institutional lender as collateral for a credit facility is a standard permitted transfer under 144A. The Security Agreement and Pledge Agreement will address transfer mechanics. STC, as transfer agent, will acknowledge the pledge via the Control Agreement.

**Evidence:** `03_COLLATERAL_DOCUMENTATION/03.01 Private Placement Memorandum (May 29, 2020).pdf`  
**CP:** CP-06  
**Gap:** ðŸŸ¢ Standard 144A pledge structure

---

### Q-15: Any litigation, liens, or adverse claims?

**Who asks:** Counsel

**Best answer:**  
No. OPTKAS1 LLC has no pending litigation, no existing liens on the collateral, and no adverse claims. The SPV was formed December 19, 2025 and has conducted no business other than acquiring and holding the collateral notes. Officer Certificate confirming no default and no litigation will be delivered at closing (CP-36). UCC search will confirm no prior filings (CP-33). Negative lien officer certificate available now (CP-22).

**Evidence:** `02_ENTITY_DOCUMENTS/Officer_Certificate_No_Liens.pdf`  
**CP:** CP-22, CP-36  
**Gap:** ðŸŸ¢ Officer certificate form ready; UCC search expected clean

---

## BLOCK D: COMPLIANCE â€” KYC, AML & SOURCE OF FUNDS

---

### Q-16: Who are UBOs and control persons?

**Who asks:** Compliance / BSA Officer

**Best answer:**  
OPTKAS1 LLC is managed by Jimmy as sole Manager with full authority per the Operating Agreement. UBO disclosure available upon compliance team request after NDA execution. Government-issued ID, proof of address, and background information for all beneficial owners provided per lender's KYC requirements. Entity-level KYC (formation docs, operating agreement, UBO structure) available immediately.

**Evidence:** `06_COMPLIANCE/06.06 UBO Disclosure.pdf` + `06_COMPLIANCE/06.01 KYC Package â€” Entity.pdf`  
**CP:** CP-14  
**Gap:** ðŸŸ¢ Available upon Level C access request

---

### Q-17: Source of funds for collateral acquisition?

**Who asks:** Compliance / AML

**Best answer:**  
Notes acquired by OPTKAS1 LLC pursuant to Subscription Agreement with TC Advantage Traders, Ltd. Cost basis $3B for $5B face value ($6M per note Ã— 500 notes). Subscription was funded through SPV capital contributions. Source of funds documentation including Subscription Agreement and payment records available upon NDA.

**Evidence:** `06_COMPLIANCE/06.04 Source of Funds Statement.pdf` + `03_COLLATERAL_DOCUMENTATION/03.05 Subscription Agreement.pdf`  
**CP:** CP-10, CP-23  
**Gap:** ðŸŸ¡ CP-23 â€” Evidence of $3B cost basis funding (wire confirmation or escrow close memo) â€” available upon request. This is a new CP from Issuance Resolution integration.

---

### Q-18: Sanctions/OFAC screening results?

**Who asks:** Compliance

**Best answer:**  
Borrower provides Officer Certificate certifying no beneficial owner, manager, or affiliate appears on any OFAC sanctions list (SDN, Consolidated, Sectoral). Borrower cooperates with lender's independent screening and provides all information needed for lender's own OFAC/BSA compliance process. Self-certification form ready.

**Evidence:** `06_COMPLIANCE/06.03 OFAC / Sanctions Certification.pdf`  
**CP:** CP-24  
**Gap:** ðŸŸ¢ Certification form ready

---

### Q-19: Any PEP exposure?

**Who asks:** Compliance

**Best answer:**  
To borrower's knowledge, no beneficial owner or control person of OPTKAS1 LLC is a Politically Exposed Person. PEP screening results available as part of the full KYC package. Borrower will cooperate with lender's independent PEP screening.

**Evidence:** `06_COMPLIANCE/06.02 KYC Package â€” Manager / UBOs.pdf`  
**CP:** CP-15  
**Gap:** ðŸŸ¡ PEP-specific screening result not separately documented. **Minimally invasive fix:** Add PEP self-certification to Officer Certificate package. Effort: 1 BD.

---

### Q-20: Any cross-border restrictions affecting enforcement or cash movement?

**Who asks:** Compliance / Counsel

**Best answer:**  
Borrower (OPTKAS1 LLC) is a Wyoming entity. Notes held at STC in Texas. All enforcement via US courts and Wyoming UCC. Cash proceeds via EagleBank (Maryland). No cross-border enforcement required. Issuer is Bahamas-domiciled, but K. Knowles opinion covers Bahamas law aspects. No FX restrictions â€” all transactions in USD. No OFAC-restricted jurisdiction exposure.

**Evidence:** `05_LEGAL/05.01 Legal Opinion â€” K. Knowles & Co.pdf`  
**CP:** CP-09  
**Gap:** ðŸŸ¢ All US-based enforcement; no cross-border restrictions

---

## BLOCK E: ALL â€” COMMERCIAL TERMS, TIMELINE & GAPS

---

### Q-21: Pricing, covenants, reporting cadence, events of default?

**Who asks:** Credit MD / Analyst

**Best answer:**  
Pricing: borrower proposes SOFR + spread (market-dependent, typically 400â€“600 bps). Covenants: collateral coverage â‰¥ 200%, monthly BBC, quarterly STC confirmation, quarterly financials, annual audit, no additional liens, no rehypothecation, SPV maintenance. Events of default: standard ABL (coverage breach, payment default, material adverse change, covenant breach, cross-default). Full terms in Loan Commitment Package.

**Evidence:** `08_LENDER_PACKAGE/08.01 Loan Commitment Package (v2).pdf`  
**CP:** CP-29 (Facility Agreement)  
**Gap:** ðŸŸ¢ Pre-formatted in Loan Commitment Package; customized during negotiation

---

### Q-22: Reporting â€” borrowing base frequency and format?

**Who asks:** Analyst / Portfolio Manager

**Best answer:**  
Monthly Borrowing Base Certificate (PDF) showing: collateral face value, cost basis, advance rate, calculated availability, coverage ratio. Quarterly STC position confirmation direct from STC. Quarterly borrower financial statements. Monthly covenant compliance certificate. Annual audit (CPA opinion). Template available immediately.

**Evidence:** `07_FINANCIAL/07.01 Borrowing Base Certificate (initial).pdf`  
**CP:** CP-47  
**Gap:** ðŸŸ¢ Template ready; populate at closing

---

### Q-23: Insurance â€” insurer, limits, endorsements process?

**Who asks:** Risk Officer / Credit MD

**Best answer:**  
Broker: C.J. Coleman & Co Ltd (FCA #30820, Lloyd's COL/879). Sum insured: $625M USD. Confirmed by letter dated March 6, 2024 (John Collier). FCA-registered â€” verify at FCA Financial Services Register #30820. Endorsement process: lender named as additional insured and loss payee upon request. Turnaround: 5â€“7 BD from C.J. Coleman. Full policy schedule and participating Lloyd's syndicates list available upon request.

**Evidence:** `04_INSURANCE/04.01 Lloyd's Insurance Confirmation Letter (March 6, 2024).pdf` + `09_VERIFICATION/09.04 FCA Register Verification Instructions.pdf`  
**CP:** CP-08, CP-34, CP-41  
**Gap:** ðŸŸ¡ CP-34 (lender-named endorsement) + CP-41 (full policy schedule) â€” 5â€“7 BD turnaround from broker. Pre-alert C.J. Coleman upon term sheet.

---

### Q-24: Are there any third-party consents required (custodian/issuer)?

**Who asks:** Counsel

**Best answer:**  
STC must acknowledge the Account Control Agreement (standard â€” STC is a professional transfer agent). No issuer consent required for pledge under 144A. No government or regulatory consent required. EagleBank must acknowledge escrow role. All consents are standard and obtainable within the closing process.

**Evidence:** `05_LEGAL/05.05 Account Control Agreement â€” STC.pdf`  
**CP:** CP-31, CP-35  
**Gap:** ðŸŸ¢ Standard consents; STC and EagleBank cooperation expected

---

### Q-25: What is the closing timeline and gating items?

**Who asks:** All

**Best answer:**  
Target: 4â€“8 weeks from NDA to closing (varies by lender). Gating items:

| # | Gating Item | CP ID | Lead Time | Status |
|:--|:-----------|:------|:----------|:-------|
| 1 | Valuation memo / BOV | CP-18 | 5â€“10 BD | **#1 priority** â€” produces IC comfort |
| 2 | Holder-specific STC statement | CP-21 | 3â€“5 BD | Request upon engagement |
| 3 | Lender counsel engagement | CP-38 | 2â€“3 weeks | Lender-dependent |
| 4 | Control Agreement execution | CP-31 | 1â€“2 weeks | Tri-party coordination |
| 5 | Insurance endorsements | CP-34 | 5â€“7 BD | C.J. Coleman turnaround |
| 6 | UCC-1 filing | CP-33 | Filing day | Ready to file |

Everything else is on file or staged for 1â€“5 BD delivery. 11 items deliverable immediately, 35 staged, 11 lender-dependent.

**Evidence:** Full CP Tracker (CP_TRACKER.md) + NDA-to-Term Sheet Runbook  
**CP:** CP-35  
**Gap:** ðŸŸ¡ CP-18 (valuation) is the only non-standard gating item. All others are execution CPs.

---

## GAP ANALYSIS SUMMARY

### ðŸŸ¢ No Gap (immediately deliverable or standard execution)

| Category | Count |
|:---------|:------|
| Documents on file, verified, deliverable same day | 11 |
| Templates staged, deliverable within 1â€“5 BD | 35 |
| Standard execution CPs (UCC filing, control agreement, etc.) | â€” |

### ðŸŸ¡ Gaps Identified (require action)

| # | Gap | CP ID | Fix | Effort | Priority |
|:--|:----|:------|:----|:-------|:---------|
| 1 | Valuation memo / Broker Opinion of Value | CP-18 | Commission BOV anchored to $3B cost basis | 5â€“10 BD | **#1 â€” Primary IC gating item** |
| 2 | Holder-specific STC position statement | CP-21 | Request from STC upon lender engagement | 3â€“5 BD | High â€” execution CP |
| 3 | Evidence of $3B cost basis funding | CP-23 | Compile subscription close memo + wire evidence | 2â€“3 BD | Medium â€” supports SoF narrative |
| 4 | PEP self-certification | (add to CP-15) | Add PEP line to Officer Certificate | 1 BD | Low â€” minimally invasive |
| 5 | Full insurance policy schedule | CP-41 | Request from C.J. Coleman | 5â€“7 BD | Medium â€” pre-alert broker |
| 6 | Borrower financial snapshot | CP-16 | Prepare 1â€“2 page unaudited SPV summary | 2 BD | Medium â€” helps IC psychologically |

### ðŸ”´ Structural Gaps: **None**

> There is nothing structural left that would kill the deal. Everything remaining is execution, not credibility.

---

## UPDATED FUNDING PROBABILITY

| Stage | Probability |
|:------|:-----------|
| Before operationalization | ~70â€“75% |
| **Now (with CP tracker + runbook + silos + diligence pack)** | **80â€“85%** |
| + Valuation memo / BOV (CP-18) | **85â€“90%** |
| + STC holder statement (CP-21) + borrower financial (CP-16) | **90%+** |
| Term sheet signed | **Near-certain close barring macro shock** |

---

## CALL PREPARATION CHECKLIST

Before any diligence call:

- [ ] Review all 25 answers â€” know them cold
- [ ] Have CP Tracker open â€” know status of every CP
- [ ] Have data room access ready (can share screen if needed)
- [ ] Have STC contact info ready (offer live verification)
- [ ] Have K. Knowles contact info ready (counsel-to-counsel)
- [ ] Have C.J. Coleman contact info ready (insurance questions)
- [ ] Know the specific lender's facility target and tier
- [ ] Review lender-specific Wave 1 package before call
- [ ] Prepare the Issuance Resolution standard sentence:
  > "The Notes were duly authorized by board resolution dated January 22, 2026, issued in book-entry form, and recorded by Securities Transfer Corporation as transfer agent. Total outstanding: $5,000,000,000 (500 notes Ã— $10,000,000). Cost basis: $3,000,000,000. Fully paid and non-assessable."

---

## POST-CALL ACTIONS

| Action | Owner | Timeline |
|:-------|:------|:---------|
| Update Q&A Log in lender silo | Borrower | Same day |
| File meeting notes in `10_CORRESPONDENCE/[LENDER]/Meeting_Notes/` | Borrower | Same day |
| Send follow-up email summarizing key points + next steps | Borrower | Next BD |
| Deliver any documents requested during call | Borrower | Per commitment |
| Update CP Tracker with lender-specific status | Borrower | Same day |
| Update REQUESTS_INTAKE.md with all outstanding asks | Borrower | Same day |
| Advance to next Runbook step as appropriate | Borrower | Per timeline |

---

*This simulation pack is maintained by OPTKAS1 LLC. Contact jimmy@optkas.com for call scheduling and preparation.*
